达瑞动态
达瑞动态
DARUI NEWS
健康视界 | PAPP-A——孕早期子痫前期预测的有效指标
加载中...
2023.05.04

参考文献:

[1] Hu J, Gao J, Liu J, et al. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China[J]. Ultrasound in Obstetrics & Gynecology, 2021, 58(4): 529-539.

[2] Chappell L C, Cluver C A, Tong S. Pre-eclampsia[J]. The Lancet, 2021, 398(10297): 341-354.

[3]李春艳,夏卿,龙伟.子痫前期联合筛查的研究进展[J].现代妇产科进展,2022,31(10):779-782.

[4]Spencer K. Age related detection and false positive rates when screening for Down's Syndrome in the first trimester using fetal nuchal translucency and maternal serum free βhCG and PAPP-A[J]. British Journal of Obstetrics and Gynaecology, 2001, 108(10): 1043-1046.

[5]Orosz L, Orosz G, Veress L, et al. Screening for preeclampsia in the first trimester of pregnancy in routine clinical practice in Hungary[J]. Journal of biotechnology, 2019, 300: 11-19.

[6]徐晓冬,尚丽新,曲冬颖.孕早期血清胎盘生长因子、妊娠相关蛋白-A、β-人绒毛膜促性腺激素检测联合子宫动脉血流参数对子痫前期预测价值研究[J].临床军医杂志,2021,49(01):44-46+49.




Copyright © 2023 广州市达瑞生物技术股份有限公司 粤ICP备2021150054号

Powered by vancheer